Renaissance Technologies’s Cumberland Pharmaceuticals CPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.66M Sell
494,963
-8,400
-2% -$28.1K ﹤0.01% 2233
2025
Q1
$2.13M Sell
503,363
-3,800
-0.7% -$16.1K ﹤0.01% 1956
2024
Q4
$1.2M Sell
507,163
-21,000
-4% -$49.8K ﹤0.01% 2388
2024
Q3
$676K Sell
528,163
-10,000
-2% -$12.8K ﹤0.01% 2648
2024
Q2
$823K Sell
538,163
-4,500
-0.8% -$6.89K ﹤0.01% 2435
2024
Q1
$912K Sell
542,663
-7,200
-1% -$12.1K ﹤0.01% 2542
2023
Q4
$985K Sell
549,863
-5,900
-1% -$10.6K ﹤0.01% 2419
2023
Q3
$1.05M Sell
555,763
-4,980
-0.9% -$9.41K ﹤0.01% 2257
2023
Q2
$824K Sell
560,743
-10,920
-2% -$16K ﹤0.01% 2584
2023
Q1
$1.12M Sell
571,663
-10,300
-2% -$20.1K ﹤0.01% 2404
2022
Q4
$1.31M Sell
581,963
-14,900
-2% -$33.5K ﹤0.01% 2370
2022
Q3
$1.44M Sell
596,863
-25,365
-4% -$61.1K ﹤0.01% 2264
2022
Q2
$1.29M Sell
622,228
-22,535
-3% -$46.8K ﹤0.01% 2533
2022
Q1
$1.82M Buy
644,763
+38,100
+6% +$107K ﹤0.01% 2296
2021
Q4
$2.83M Sell
606,663
-57,901
-9% -$270K ﹤0.01% 1885
2021
Q3
$1.78M Sell
664,564
-36,899
-5% -$98.9K ﹤0.01% 2174
2021
Q2
$2M Sell
701,463
-51,590
-7% -$147K ﹤0.01% 2262
2021
Q1
$2.28M Buy
753,053
+77,894
+12% +$236K ﹤0.01% 2132
2020
Q4
$1.99M Buy
675,159
+75,501
+13% +$223K ﹤0.01% 2114
2020
Q3
$1.93M Buy
599,658
+200
+0% +$642 ﹤0.01% 2156
2020
Q2
$2M Buy
599,458
+127,800
+27% +$426K ﹤0.01% 2189
2020
Q1
$1.71M Buy
471,658
+2,320
+0.5% +$8.42K ﹤0.01% 2128
2019
Q4
$2.42M Buy
469,338
+200
+0% +$1.03K ﹤0.01% 2230
2019
Q3
$2.78M Buy
469,138
+27,561
+6% +$163K ﹤0.01% 2098
2019
Q2
$2.81M Buy
441,577
+50,800
+13% +$324K ﹤0.01% 2155
2019
Q1
$2.27M Buy
390,777
+9,403
+2% +$54.6K ﹤0.01% 2245
2018
Q4
$2.3M Sell
381,374
-97
-0% -$585 ﹤0.01% 2160
2018
Q3
$2.18M Buy
381,471
+4,262
+1% +$24.3K ﹤0.01% 2228
2018
Q2
$2.31M Buy
377,209
+23,709
+7% +$145K ﹤0.01% 2195
2018
Q1
$2.36M Buy
353,500
+23,200
+7% +$155K ﹤0.01% 2244
2017
Q4
$2.43M Buy
330,300
+14,295
+5% +$105K ﹤0.01% 2228
2017
Q3
$2.23M Buy
316,005
+25,152
+9% +$178K ﹤0.01% 2244
2017
Q2
$2.04M Buy
290,853
+20,613
+8% +$144K ﹤0.01% 2257
2017
Q1
$1.88M Buy
270,240
+13,240
+5% +$91.9K ﹤0.01% 2275
2016
Q4
$1.41M Buy
257,000
+9,900
+4% +$54.5K ﹤0.01% 2392
2016
Q3
$1.24M Buy
247,100
+11,800
+5% +$59.1K ﹤0.01% 2456
2016
Q2
$1.06M Buy
235,300
+12,700
+6% +$57.2K ﹤0.01% 2508
2016
Q1
$999K Buy
222,600
+5,400
+2% +$24.2K ﹤0.01% 2595
2015
Q4
$1.14M Buy
217,200
+18,620
+9% +$97.9K ﹤0.01% 2401
2015
Q3
$1.15M Buy
198,580
+1,880
+1% +$10.8K ﹤0.01% 2313
2015
Q2
$1.41M Buy
196,700
+26,512
+16% +$190K ﹤0.01% 2279
2015
Q1
$1.13M Buy
170,188
+49,288
+41% +$328K ﹤0.01% 2243
2014
Q4
$723K Buy
120,900
+36,800
+44% +$220K ﹤0.01% 2299
2014
Q3
$415K Buy
84,100
+7,300
+10% +$36K ﹤0.01% 2373
2014
Q2
$346K Sell
76,800
-18,797
-20% -$84.7K ﹤0.01% 2437
2014
Q1
$430K Sell
95,597
-37,803
-28% -$170K ﹤0.01% 2401
2013
Q4
$682K Sell
133,400
-44,262
-25% -$226K ﹤0.01% 2248
2013
Q3
$805K Sell
177,662
-73,206
-29% -$332K ﹤0.01% 2107
2013
Q2
$1.28M Buy
+250,868
New +$1.28M ﹤0.01% 1811